1869912-40-2 (AZD 5153 6-Hydroxy-2-naphthoic acid;AZD-5153 6-Hydroxy-2-naphthoic acid,AZD5153 6-Hydroxy-2-naphthoic acid)

AZD5153结晶体(API形式);BET/BRD4溴结构域抑制剂(AZD5153 6-HYDROXY-2-NAPHTHOIC ACID);AZD51536-羟基-2-萘甲酸;化合物AZD5153 6-HYDROXY-2-NAPHTHOIC ACID;

AZD5153 (6-Hydroxy-2-naphthoic acid);AZD 5153 6-Hydroxy-2-naphthoic acid;AZD-5153 6-Hydroxy-2-naphthoic acid;AZD5153 6-Hydroxy-2-naphthoic acid;78VBM99SEV;(R)-4-(2-(4-(1-(3-methoxy-[1,2,4]triazolo[4,3-b]pyridazin-6-yl)piperidin-4-yl)phenoxy)ethyl)-1,3-dimethylpiperazin-2-one 6-hydroxy-2-naphthoate;BCP20066;s8344;2-Naphthalenecarboxylic acid, 6-h;AZD5153;AZD5153 (API form);1869912-39-9 FREE BASE;AZD5153 (API form)(1869912-39-9 free base);AZD515; AZD-5153 6-HYDROXY-2-NAPHTHOIC ACID;AZD-5153 HNT salt;CS-6442;SCHEMBL17477281;C73588;EX-A2548;1869912-40-2 (HNT salt);AC-36126;AZD5153 HNT salt;DA-61377;AZD5153 6-Hydroxy-2-naphthoic acid; AZD-5153 HNT salt;AZD-5153 HNT salt;AZD 5153 6-Hydroxy-2-naphthoic acid; AZD-5153 6-Hydroxy-2-naphthoic acid;AZD-5153; AZD5153; AZD 5153;AKOS037648823;1869912-40-2;CCG-270353;BS-15731;UNII-78VBM99SEV;HY-100653A;6-hydroxynaphthalene-2-carboxylic acid;(3R)-4-[2-[4-[1-(3-methoxy-[1,2,4]triazolo[4,3-b]pyridazin-6-yl)piperidin-4-yl]phenoxy]ethyl]-1,3-dimethylpiperazin-2-one;AZD5153 6-Hydroxy-2-naphthoic acid?;

UNZQBHXKCHECEC-GMUIIQOCSA-N

1S/C25H33N7O3.C11H8O3/c1-18-24(33)29(2)14-15-30(18)16-17-35-21-6-4-19(5-7-21)20-10-12-31(13-11-20)23-9-8-22-26-27-25(34-3)32(22)28-23;12-10-4-3-7-5-9(11(13)14)2-1-8(7)6-10/h4-9,18,20H,10-17H2,1-3H3;1-6,12H,(H,13,14)/t18-;/m1./s1

O(C([H])([H])C([H])([H])N1C([H])([H])C([H])([H])N(C([H])([H])[H])C([C@@]1([H])C([H])([H])[H])=O)C1C([H])=C([H])C(=C([H])C=1[H])C1([H])C([H])([H])C([H])([H])N(C2C([H])=C([H])C3=NN=C(N3N=2)OC([H])([H])[H])C([H])([H])C1([H])[H].O([H])C1C([H])=C([H])C2C([H])=C(C(=O)O[H])C([H])=C([H])C=2C=1[H]